These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5563839)

  • 1. [Case of lung carcinoma treated with massive intravenous administration of Endoxan].
    Frontczak J
    Gruzlica; 1971 May; 39(5):431-2. PubMed ID: 5563839
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of lung cancer with Endoxan, with reference to the effect of massive intermittent administration].
    Matsuda M; Nishihara H; Komatsu T; Hattori S; Terasawa T
    Saishin Igaku; 1967 Aug; 22(8):1808-20. PubMed ID: 6081168
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the administration of massive doses of endoxan in pulmonary neoplasms].
    Górecki R; Brodziak R; Gondorowicz K; Stanek S
    Gruzlica; 1969 Mar; 37(3):251-4. PubMed ID: 4182112
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience with Endoxan massive treatment].
    Kosaki G; Aoki Y; Kusakabe H; Taniguchi K; Takagi H
    Saishin Igaku; 1966 Nov; 21(11):2527-37. PubMed ID: 5979032
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclophosphamide therapy in Wegener's granulomatosis.
    Novack SN; Pearson CM
    N Engl J Med; 1971 Apr; 284(17):938-42. PubMed ID: 5551803
    [No Abstract]   [Full Text] [Related]  

  • 6. [Remarkable effects of endoxan on a case of giant orbital carcinoma].
    Matsubara T
    Nihon Ganka Kiyo; 1968 May; 19(5):610-4. PubMed ID: 5748893
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment with large doses of Endoxan].
    Araujo E; Estevez R; Sanchez Suarez R; Chacon R; Gonzalez G
    Med Monatsschr; 1967 Aug; 21(8):371-3. PubMed ID: 5597100
    [No Abstract]   [Full Text] [Related]  

  • 8. [Shock doses of endoxan in the therapy of malignant lung neoplasms (based on personal observations)].
    Ratajek M
    Wiad Lek; 1970 Jan; 23(1):15-8. PubMed ID: 5412426
    [No Abstract]   [Full Text] [Related]  

  • 9. [Incidence and degree of intolerance and toxic effect of cytostatics in the treatment of lung cancer].
    Traczyk K; Zych D; Decker E; Radziukiewicz-Byszewska D; Krychniak W; Marzinek M; Pecyna-Sielewicz J; Ponahajba A; Siekierzyńska A; Słupek A
    Pneumonol Pol; 1980; 48(12):831-40. PubMed ID: 7220354
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapy of lung cancer with special reference to combined therapy with mitomycin and endoxan].
    Oka S; Watanabe M; Kato S; Tamagawa S
    Gan No Rinsho; 1966 May; 12(5):271-7. PubMed ID: 6010949
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cisplatin-Vepeside versus Endoxan-Vepeside in the treatment of small cell bronchial cancer. A randomized study].
    Heckmayr M; Gatzemeier U; Hossfeld DK; Koschel G; Thies F; Zschaber R
    Pneumologie; 1990 Feb; 44 Suppl 1():256-7. PubMed ID: 2164193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of anaplastic carcinoma of the lung with VP 16-213].
    Sanz Ortíz J; Saiz García F
    Med Clin (Barc); 1982 Oct 16-31; 79(7):322-4. PubMed ID: 6294420
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative results of massive endoxan stoss therapy and treatment of malignant tumors with proresid].
    Gebhardt KH; Becher R
    Med Welt; 1967 Jul; 30():1705-7. PubMed ID: 5616405
    [No Abstract]   [Full Text] [Related]  

  • 14. [TREATMENT OF ENDOTHORACIC TUMORS BY INTRAVENOUS INJECTION OF ENDOXAN IN MASSIVE AND SPACED DOSES].
    MANNES P; DERRIKS R; DELPORTE F; EVERAERTS J
    Lille Med; 1964; 9():SUPPL:124-8. PubMed ID: 14274360
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of lung neoplasms with massive single doses of cyclophosphane in combination with the protector cystaphos].
    Batinov IN; Trakhtenberg AK; Trubnikova EN; Sukhin GM
    Vopr Onkol; 1971 Dec; 17(12):83-4. PubMed ID: 5144166
    [No Abstract]   [Full Text] [Related]  

  • 16. [Early results of bronchogenic carcinoma treatment with massive doses of cyclophosphamide].
    Kochnowski G; Rozek G; Wisńiewski J
    Wiad Lek; 1976 Feb; 29(4):270-1. PubMed ID: 1251645
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of nonresectable cancer of the lung with hydroxyurea (NSC-32065) given intermittently.
    Kaung DT; Sbar S; Patno ME
    Cancer Chemother Rep; 1971 Feb; 55(1):87-9. PubMed ID: 5121655
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of pulmonary metastasis in breast neoplasms using endoxan].
    Rittmeyer K; Pöhls PH; Gregl A
    Strahlentherapie; 1969 Jun; 137(6):663-9. PubMed ID: 5355161
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.
    Chahinian PA; Arnold DJ; Cohen JM; Purpora DP; Jaffrey IS; Teirstein AS; Kirschner PA; Holland JF
    JAMA; 1977 May; 237(22):2392-6. PubMed ID: 576939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MEP therapy of advanced lung cancer].
    Komuro Y; Ohnishi M; Saitoh A; Morohashi Y
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2688-91. PubMed ID: 2820313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.